No Data
No Data
Piper Sandler Maintains Colgate-Palmolive(CL.US) With Buy Rating, Maintains Target Price $121
Piper Sandler analyst Korinne Wolfmeyer maintains $Colgate-Palmolive(CL.US)$ with a buy rating, and maintains the target price at $121.According to TipRanks data, the analyst has a success rate of 37.
Express News | Colgate-Palmolive Co : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $121
Piper Sandler Initiates Colgate-Palmolive(CL.US) With Buy Rating, Announces Target Price $121
Piper Sandler analyst Korinne Wolfmeyer initiates coverage on $Colgate-Palmolive(CL.US)$ with a buy rating, and sets the target price at $121.According to TipRanks data, the analyst has a success
Overweight Quality Stocks With Positive EPS Revision - MS
Colgate-Palmolive Company and 1,000 Dreams Fund Partner to Launch Colgate-Palmolive Scholars Program for Women in Healthcare
United States Cosmetics Market Report and Company Analysis 2024-2032 Featuring Coty, Procter & Gamble, Estee Lauder, Colgate-Palmolive, Johnson & Johnson, Revlon, and Mary Kay - ResearchAndMarkets.com